By Sherri Oslick --
About
Court Report: Each week we will report briefly on recently filed
biotech and pharma cases, and a few interesting cases will be selected
for periodic monitoring.
Eli Lilly and Company v. Sun Pharmaceutical Industries Ltd. et al.
1:08-cv-01629; filed December 4, 2008 in the Southern District of Indiana
Infringement of U.S. Patent No. 5,023,269 ("3-Aryloxy-3-Substituted Propanamines," issued June 11, 1991) following a Paragraph IV certification as part of Sun's filing of an ANDA to manufacture a generic version of Lilly's Cymbalta® (duloxetine hydrochloride, used to treat depression and generalized anxiety disorder and for the management of diabetic peripheral neuropathic pain and fibromyalgia). View the complaint here.
Purac Biochem B.V. v. Dudas
1:08-cv-02067; filed December 1, 2008 in the District Court of the District of Columbia
Review and correction of the patent term adjustment calculation made by the USPTO for U.S. Patent No. 7,410,556 ("Purification of Aqueous Solutions of Organic Acids," issued August 12, 2008). To view the complaint and additional coverage of this case, please see "More Patentees Follow Wyeth's Lead in Seeking Additional PTA."
Molecular Insight Pharmaceuticals, Inc. et al. v. Dudas
1:08-cv-02065; filed December 1, 2008 in the District Court of the District of Columbia
Review and correction of the patent term adjustment calculation made by the USPTO for U.S. Patent No. 7,381,745 ("Ligands for Metabotropic Glutamate Receptors and Inhibitors of NAALADase," issued June 3, 2008). View the complaint here.
Molecular Insight Pharmaceuticals, Inc. v. Dudas
1:08-cv-02068; filed December 1, 2008 in the District Court of the District of Columbia
Review and correction of the patent term adjustment calculation made by the USPTO for U.S. Patent No. 7,381,399 ("Technetium-Dipyridine Complexes, and Methods of Use Thereof," issued June 3, 2008). To view the complaint and additional coverage of this case, please see "More Patentees Follow Wyeth's Lead in Seeking Additional PTA."
Solvay Pharmaceuticals GmbH v. Dudas
1:08-cv-02053; filed December 1, 2008 in the District Court of the District of Columbia
Review and correction of the patent term adjustment calculation made by the USPTO for U.S. Patent No. 7,381,729 ("4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7H-pyrrolo [2,3D] pyrimidine hydrogen mesylate, Its Polymorphic Forms, and Methods for Making Same," issued June 3, 2008). To view the complaint and additional coverage of this case, please see "More Patentees Follow Wyeth's Lead in Seeking Additional PTA."
Biogen Idec Inc. v. Dudas
1:08-cv-02061; filed December 1, 2008 in the District Court of the District of Columbia
Review and correction of the patent term adjustment calculation made by the USPTO for U.S. Patent No. 7,381,560 ("Expression and Use of Anti-CD20 Antibodies," issued June 3, 2008). To view the complaint and additional coverage of this case, please see "More Patentees Follow Wyeth's Lead in Seeking Additional PTA."
Comments